StonvexLoading…
StonvexStonvexStonvexCore line items from ACAD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $268.06M | $1.07B | $787.52M | $508.88M |
Operating Income | $-4.62M | $104.81M | $87.42M | $51.66M |
Net Income | $3.64M | $391.00M | $117.43M | $45.65M |
EPS (Diluted) | $0.02 | $2.30 | $0.69 | $0.27 |
Total Assets | $1.61B | $1.56B | $1.33B | $1.23B |
Total Liabilities | $357.16M | $336.81M | $413.50M | $403.17M |
Cash & Equivalents | $282.21M | $177.69M | $258.00M | $253.64M |
Free Cash Flow OCF − CapEx | $28.77M | $105.15M | $157.88M | $83.98M |
Shares Outstanding | 171.09M | 170.31M | 169.15M | 168.61M |